Mar 21, 2019 - British pharma giant GlaxoSmithKline joined the recent groundswell of high-grade corporate bond issuers Monday to sell new debt.The UK-based firm priced US$3.5bn worth of ‘A’-rated, three-, five- and
Mar 19, 2019 - Precision BioSciences intends to raise $126.4 million in an IPO of its common stock.The firm is developing a gene editing platform for disease treatments, research, and crop modification applications.
Mar 19, 2019 - Genfit S.A. is aiming to raise $130 million in a global IPO and European private placement.The firm is in late-stage trials for its primary treatment candidate for NASH.While its Elafibranor candidate
Mar 15, 2019 - BMO Capital Markets issues rating change for GILD
Mar 14, 2019 - A brand-new vertical retail palace — don’t call it a mall — opens at Hudson Yards, New York’s biggest, shiniest new multibillion-dollar development. Will crowds follow?
Mar 14, 2019 - Agenus (AGEN) gets a $7.5-million milestone payment from Gilead following the FDA acceptance of the company's IND filing for AGEN1423. Shares rise.
Mar 09, 2019 - Precision BioSciences is expected to do an IPO soon that is expected to be valued at $100 million.The genome editing ARCUS technology platform offers a lot of potential using a fully synthetic enzyme
Mar 08, 2019 - Gilead (GILD) presents encouraging data on two leading HIV regimens, Bikatrvy and Descovy.
Mar 07, 2019 - Gilead (GILD) presents encouraging data on two leading HIV regimens, Bikatrvy and Descovy.
Mar 05, 2019 - Dividend income hit $279 in February, up 55% Y/Y and 17.2% sequentially.The big increase is heavily boosted by the first annual dividend from Siemens Healthineers which easily compensated for the exit